4.4 out of 5 stars
(81 Ratings)
Around the world, teams focused on risk management, procurement, and compliance face increasing demands to navigate the challenges posed by geopolitical and business risks. The intricacies of both domestic and international operations, alongside a myriad of regulations, significantly influence third-party risks. Therefore, it is essential for organizations to take a proactive approach in managing their relationships with third parties. This innovative platform, leveraging the D&B Data Cloud's extensive database of over 520 million global business records and more than 2 billion updates each year, serves as an AI-driven tool that continually assesses and mitigates counterparty risk. D&B Risk Analytics incorporates top-tier risk data, providing alerts on high-risk transactions and identifying connections across a billion data points, all of which empower businesses to make well-informed choices. Additionally, the platform's intelligent workflows facilitate rapid and comprehensive screening processes, ensuring timely alerts on critical business metrics. As a result, companies can enhance their risk management strategies and improve their overall operational resilience.
Learn more about D&B Risk Analytics
4.7 out of 5 stars
(18 Ratings)
Predict360, developed by 360factors, serves as a comprehensive risk and compliance management platform designed to streamline workflows and improve reporting for various financial institutions, including banks, credit unions, and insurance companies. This cloud-based SaaS solution consolidates essential components such as regulations, compliance management, risk assessments, controls, key risk indicators (KRIs), audits, policies, and training into one cohesive platform while offering powerful analytics and insights that help clients foresee risks and enhance compliance efforts.
If your current Governance, Risk, and Compliance (GRC) system isn't equipped with an effective analytics and business intelligence tool for creating insightful reports for executives and board members, consider Lumify360 from 360factors. This predictive analytics platform can seamlessly integrate with any existing GRC, allowing you to maintain your workflow processes while equipping stakeholders with the timely reports and dashboards they require for informed decision-making. With these advanced tools at your disposal, you'll be better positioned to navigate the complexities of regulatory compliance and risk management.
Learn more about Predict360
Paige
Paige's innovative offerings have the capability to transform the way pathologists operate by enhancing the certainty of their diagnoses. The company is dedicated to leading a new frontier in clinical tools and predictive assessments that not only empower pathologists but also redefine the landscape of oncology. By leveraging cutting-edge AI solutions, Paige is setting the stage for the future of pathology. The Paige Platform is a robust, secure solution that guarantees interoperability with laboratory information systems (LIS), seamlessly integrates various scanners, provides cloud storage, streamlines case management, allows for image review through FullFocus®, and features sophisticated AI applications. The Paige Prostate suite of AI tools is meticulously crafted to assist pathologists in pinpointing suspicious regions, grading and quantifying tissue samples, and evaluating perineural invasion (PNI) in prostate needle core biopsies. In a similar vein, the Paige Breast suite of AI applications aids pathologists in analyzing breast cancer by facilitating the identification of malignancies in breast biopsies and detecting metastases in lymph nodes related to breast tissue. These collective advancements not only boost diagnostic precision but also significantly enhance patient outcomes in the realm of oncology, ultimately leading to a more effective and supportive healthcare environment. As pathologists adopt these tools, the potential for improved patient care and treatment strategies becomes increasingly promising.
Learn more about Paige
Qritive
Improving the speed, accuracy, and cost-effectiveness of cancer diagnoses is essential, given that one in three people are likely to confront this illness in their lives. The existing diagnostic methods, however, are often slow and expensive, primarily due to a shortage of sophisticated automated tools that can aid healthcare providers. Qritive seeks to overcome this issue by providing an AI-powered solution that assists doctors in efficiently analyzing microscopy images alongside patient data. This breakthrough not only improves the diagnostic capabilities of hospitals but also results in substantial savings in healthcare costs. Furthermore, Pantheon acts as a CE-marked, vendor-neutral digital pathology platform that streamlines the entire digitization process for pathology laboratory workflows and telepathology services. It also enables thorough report generation and offers a powerful environment for AI-based analysis of whole-slide images in pathology. This innovative technology excels at differentiating between various benign conditions and malignant diseases in breast tissue, which is crucial for ensuring timely and precise treatment. By doing so, it significantly contributes to the evolution of cancer diagnostics and enhances patient outcomes in the long run.
Learn more about Qritive